Published in J Pain Symptom Manage on April 01, 1992
Sodium channel blockers for the treatment of neuropathic pain. Neurotherapeutics (2009) 0.91
Use of lidocaine patches for neuropathic pain in a comprehensive cancer centre. Pain Res Manag (2009) 0.81
Management strategies for chronic pain. Ann Rheum Dis (1996) 0.77
A prospective open-label trial of gabapentin as an adjuvant analgesic with opioids for Japanese patients with neuropathic cancer pain. Int J Clin Oncol (2010) 0.75
The Edmonton Symptom Assessment System (ESAS): a simple method for the assessment of palliative care patients. J Palliat Care (1991) 7.28
Dual-energy x-ray absorptiometry for total-body and regional bone-mineral and soft-tissue composition. Am J Clin Nutr (1990) 4.82
Occurrence, causes, and outcome of delirium in patients with advanced cancer: a prospective study. Arch Intern Med (2000) 4.60
Morphine and alternative opioids in cancer pain: the EAPC recommendations. Br J Cancer (2001) 3.40
Direct in vivo assessment of microcirculatory dysfunction in severe falciparum malaria. J Infect Dis (2008) 2.77
Quality-of-life assessment during a palliative care programme. Ann Oncol (1990) 2.67
Declines in HIV prevalence can be associated with changing sexual behaviour in Uganda, urban Kenya, Zimbabwe, and urban Haiti. Sex Transm Infect (2006) 2.65
Double-blind controlled trial of oral clodronate in patients with bone metastases from breast cancer. J Clin Oncol (1993) 2.50
Strategies to manage the adverse effects of oral morphine: an evidence-based report. J Clin Oncol (2001) 2.25
Symptom prevalence and control during cancer patients' last days of life. J Palliat Care (1990) 2.22
Comparison of two different concentrations of hyaluronidase in patients receiving one-hour infusions of hypodermoclysis. J Pain Symptom Manage (1995) 2.00
Subcutaneous morphine for dyspnea in cancer patients. Ann Intern Med (1993) 1.95
Evidence from electron microscope studies on actin paracrystals concerning the origin of the cross-striation in the thin filaments of vertebrate skeletal muscle. Proc R Soc Lond B Biol Sci (1973) 1.93
Herpes simplex type 1 induction of persistent NF-kappa B nuclear translocation increases the efficiency of virus replication. Virology (1998) 1.91
Matching and maximizing with concurrent ratio-interval schedules. J Exp Anal Behav (1983) 1.83
Correlation between c-erbB-2 amplification and risk of recurrent disease in node-negative breast cancer. Cancer Res (1991) 1.80
Biological control of crystal texture: a widespread strategy for adapting crystal properties to function. Science (1993) 1.76
Symptom control during the last week of life on a palliative care unit. J Palliat Care (1991) 1.75
Preventable deaths after injury: why are the traditional 'vital' signs poor indicators of blood loss? J Accid Emerg Med (1995) 1.71
Hospital stay following biliary tract surgery. A comparison of two community hospitals. Arch Surg (1986) 1.69
Primary breast lymphoma. An immunohistologic study of 20 new cases. Cancer (1990) 1.65
Learning complex arithmetic--an fMRI study. Brain Res Cogn Brain Res (2003) 1.61
A comparison of patient and proxy symptom assessments in advanced cancer patients. Palliat Med (1999) 1.52
Breast cancer in northern Alberta: pilot study in computerized registration. Can Med Assoc J (1977) 1.51
Prospective single blinded randomised controlled trial of two orally administered activated charcoal preparations. J Accid Emerg Med (1999) 1.49
Morphine for relief of cancer pain. Lancet (1996) 1.47
Predictors of home death in palliative care cancer patients. J Palliat Care (2000) 1.46
Estimate of survival of patients admitted to a palliative care unit: a prospective study. J Pain Symptom Manage (1992) 1.43
Optical diffraction studies of myofibrillar structure. Philos Trans R Soc Lond B Biol Sci (1971) 1.43
An upper limit on the stochastic gravitational-wave background of cosmological origin. Nature (2009) 1.42
Intrauterine growth retardation in Iowa communities with herbicide-contaminated drinking water supplies. Environ Health Perspect (1997) 1.41
Bus rounds for palliative care education in the community. CMAJ (1997) 1.41
Effect of radiation on cytokine and cytokine receptor messenger-RNA profiles in p53 wild and mutated human glioblastoma cell lines. Clin Invest Med (2001) 1.41
Flucytosine treatment of Candida arthritis. JAMA (1977) 1.40
Possible fenthion toxicity in magpies (Pica pica). Can Vet J (1981) 1.39
Follow-up of controls participating in case-control studies for cancer risk factors. Int J Epidemiol (1990) 1.38
Medical Communication Behavior System. An interactional analysis system for medical interactions. Med Care (1986) 1.38
Performance evaluation of a dual-energy x-ray bone densitometer. Calcif Tissue Int (1989) 1.38
Proximal femur geometry to detect and distinguish femoral neck fractures from trochanteric fractures in postmenopausal women. Osteoporos Int (2002) 1.37
The use of bone-graft substitutes in large bone defects: any specific needs? Injury (2011) 1.35
Opioid rotation in patients with cancer pain. A retrospective comparison of dose ratios between methadone, hydromorphone, and morphine. Cancer (1996) 1.33
Internet usage among women with breast cancer: an exploratory study. Clin Breast Cancer (2000) 1.32
Cadmium and prostatic cancer in Alberta. Can Med Assoc J (1981) 1.32
Epidemiology of prostatic cancer: a case-control study. Prostate (1990) 1.31
Frequency of symptom distress and poor prognostic indicators in palliative cancer patients admitted to a tertiary palliative care unit, hospices, and acute care hospitals. J Palliat Care (2000) 1.31
Dose ratio between morphine and methadone in patients with cancer pain: a retrospective study. Cancer (1998) 1.29
The frequency and clinical course of cognitive impairment in patients with terminal cancer. Cancer (1997) 1.25
Diffusion-weighted imaging discriminates progressive supranuclear palsy from PD, but not from the parkinson variant of multiple system atrophy. Neurology (2003) 1.25
The Relation of External Rubidium Concentration to Amounts and Rates of Uptake by Excised Potato Tuber Tissue. Plant Physiol (1955) 1.24
Cognitive failure in patients with terminal cancer: a prospective study. J Pain Symptom Manage (1992) 1.22
Standardization of femur BMD. J Bone Miner Res (1997) 1.22
The Edmonton staging system for cancer pain: preliminary report. Pain (1989) 1.21
Structure of the myosin-containing filament assembly (A-segment) separated from frog skeletal muscle. J Mol Biol (1971) 1.20
Recent x-ray diffraction studies of muscle. Q Rev Biophys (1968) 1.19
A prospective multicenter assessment of the Edmonton staging system for cancer pain. J Pain Symptom Manage (1995) 1.18
Dose ratio between morphine and hydromorphone in patients with cancer pain: a retrospective study. Pain (1997) 1.18
WHO guidelines for the use of analgesics in cancer pain. Int J Tissue React (1985) 1.18
Switching from morphine to methadone to improve analgesia and tolerability in cancer patients: a prospective study. J Clin Oncol (2001) 1.17
Geometry of proximal femur in the prediction of hip fracture in osteoporotic women. Br J Radiol (1999) 1.16
Communication between primary care physicians and radiation oncologists regarding patients with cancer treated with palliative radiotherapy. J Clin Oncol (2000) 1.16
Inhibition of cyclooxygenases by dipyrone. Br J Pharmacol (2007) 1.14
The addition of an audiocassette recording of a consultation to written recommendations for patients with advanced cancer: A randomized, controlled trial. Cancer (1999) 1.14
Current trends in Rwanda's HIV/AIDS epidemic. Sex Transm Infect (2006) 1.13
Baseline FACT-G score is a predictor of survival for advanced lung cancer. Qual Life Res (2004) 1.12
Morphogenesis of calcitic sponge spicules: a role for specialized proteins interacting with growing crystals. FASEB J (1995) 1.11
Impaired dopaminergic neurotransmission in patients with traumatic brain injury: a SPECT study using 123I-beta-CIT and 123I-IBZM. Eur J Nucl Med (2000) 1.11
Upper limits on a stochastic background of gravitational waves. Phys Rev Lett (2005) 1.11
The management of constipation in palliative care: clinical practice recommendations. Palliat Med (2008) 1.09
Cutaneous melanoma risk and phenotypic changes in large congenital nevi: a follow-up study of 46 patients. J Am Acad Dermatol (1998) 1.09
Prevalence, distress, management, and relief of pain during the last 3 months of cancer patients' life. Results of an Italian mortality follow-back survey. Ann Oncol (2009) 1.09
Effect of chemotherapy on survival in metastatic breast cancer. Breast Cancer Res Treat (1981) 1.08
Risk factors and 10-year breast cancer survival in northern Alberta. Breast Cancer Res Treat (1989) 1.08
The frequency of alcoholism among patients with pain due to terminal cancer. J Pain Symptom Manage (1995) 1.08
Effects of morphine on the dyspnea of terminal cancer patients. J Pain Symptom Manage (1990) 1.07
The frequency and correlates of dyspnea in patients with advanced cancer. J Pain Symptom Manage (2000) 1.06
A survey of mouth pain and dryness in patients with advanced cancer. Support Care Cancer (2000) 1.06
Characteristics of terminal cancer patients who committed suicide during a home palliative care program. J Pain Symptom Manage (2001) 1.06
The effects of repetitive stimulation on the action potential and the twitch of rat muscle. Acta Physiol Scand (1974) 1.05
Study of cardiovascular autonomic insufficiency in advanced cancer patients. Cancer Treat Rep (1986) 1.05
Edmonton Regional Palliative Care Program: impact on patterns of terminal cancer care. CMAJ (1999) 1.05
Clinical experience with oral methadone administration in the treatment of pain in 196 advanced cancer patients. J Clin Oncol (1996) 1.04
Maternal alcohol use and risk of orofacial cleft birth defects. Teratology (1996) 1.04
Changes in the action potential and contraction of isolated frog muscle after repetitive stimulation. Acta Physiol Scand (1971) 1.03
The impact of a regional palliative care program on the cost of palliative care delivery. J Palliat Med (2000) 1.03
A controlled trial of megestrol acetate on appetite, caloric intake, nutritional status, and other symptoms in patients with advanced cancer. Cancer (1990) 1.03
The role of ICAM-1 molecule in the migration of Langerhans cells in the skin and regional lymph node. Eur J Immunol (2001) 1.02
The effects of methotrexate (MTX) on bone. A densitometric study conducted on 59 patients with MTX administered at different doses. Ital J Orthop Traumatol (1988) 1.02
Separation of thick and thin myofilaments. J Mol Biol (1971) 1.02
Multidisciplinary symptom control clinic in a cancer center: a retrospective study. Support Care Cancer (2001) 1.01
Use of the subcutaneous route for the administration of narcotics in patients with cancer pain. Cancer (1988) 1.01
Social and demographic characteristics of patients admitted to a palliative care unit. J Palliat Care (1990) 1.01
Increased immunosuppressive vulnerability in elderly renal transplant recipients. Transplantation (2000) 1.01